Myotonic Dystrophy is an autosomal dominantly inherited multisystem disorder (MD type 1 and MD type 2). The main objective of forming a disease-oriented biobank is the structured storage of biomaterial and clinical data, both for research purposes within the Radboudumc and for (inter)national collaborations in the future. For both MD1 and MD2, investigation of DNA and pathophysiological mechanisms will be an important objective, with identification of targets for therapy.
Want to know more about these subjects? Click on the buttons below for more news.
Related news items
Quality certificate for the PBMC isolation method and cfDNA extraction method8 August 2023
Last year the Radboud Biobank participated for the first time in the IBBL Biospecimen Proficiency Testing program; an external quality assessment tool to verify the precision and accuracy of biospecimen testing methods and the efficiency of processing methods.read more
Theme Biobank and collections of Health RI launched a new project to develop a novel Dutch Biobank Standard30 March 2023
In February 2023 the theme Biobanks and Collections of Health-RI launched a new project entitled: “Dutch biobanking standard: towards harmonized, evidence-based collection, processing and storage of human biomaterials”.read more
Health-RI receives definitive follow-up funding from the National Growth Fund30 March 2023
The full funding of a total of 69 million euros has been definitively awarded to Health-RI, the national health data infrastructure for research and innovation.read more